367 related articles for article (PubMed ID: 25341739)
1. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
Walfridsson H; Walfridsson U; Nielsen JC; Johannessen A; Raatikainen P; Janzon M; Levin LA; Aronsson M; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Hansen PS
Europace; 2015 Feb; 17(2):215-21. PubMed ID: 25567068
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.
Pappone C; Vicedomini G; Augello G; Manguso F; Saviano M; Baldi M; Petretta A; Giannelli L; Calovic Z; Guluta V; Tavazzi L; Santinelli V
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):808-14. PubMed ID: 21946315
[TBL] [Abstract][Full Text] [Related]
6. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
[TBL] [Abstract][Full Text] [Related]
7. A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation.
Du X; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Yin H; Xuan J; Dong J; Ma C
Am J Cardiovasc Drugs; 2019 Dec; 19(6):569-577. PubMed ID: 31090018
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
Cosedis Nielsen J; Johannessen A; Raatikainen P; Hindricks G; Walfridsson H; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Hansen PS
N Engl J Med; 2012 Oct; 367(17):1587-95. PubMed ID: 23094720
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of the convergent procedure and catheter ablation for non-paroxysmal atrial fibrillation.
Anderson LH; Black EJ; Civello KC; Martinson MS; Kress DC
J Med Econ; 2014 Jul; 17(7):481-91. PubMed ID: 24693987
[TBL] [Abstract][Full Text] [Related]
10. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study.
Khaykin Y; Wang X; Natale A; Wazni OM; Skanes AC; Humphries KH; Kerr CR; Verma A; Morillo CA
J Cardiovasc Electrophysiol; 2009 Jan; 20(1):7-12. PubMed ID: 18803564
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland.
Åkerborg Ö; Nilsson J; Bascle S; Lindgren P; Reynolds M
Clin Ther; 2012 Aug; 34(8):1788-802. PubMed ID: 22770643
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation.
Reynolds MR; Lamotte M; Todd D; Khaykin Y; Eggington S; Tsintzos S; Klein G
Europace; 2014 May; 16(5):652-9. PubMed ID: 24390386
[TBL] [Abstract][Full Text] [Related]
13. Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction.
Chew DS; Loring Z; Anand J; Fudim M; Lowenstern A; Rymer JA; Weimer KED; Atwater BD; DeVore AD; Exner DV; Noseworthy PA; Yancy CW; Mark DB; Piccini JP
Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007094. PubMed ID: 33280436
[TBL] [Abstract][Full Text] [Related]
14. Ablation of paroxysmal atrial fibrillation using a second-generation cryoballoon catheter or contact-force sensing radiofrequency ablation catheter: A comparison of costs and long-term clinical outcomes.
Yokokawa M; Chugh A; Latchamsetty R; Ghanbari H; Crawford T; Jongnarangsin K; Cunnane R; Saeed M; Hornsby K; Krishnasamy K; Lohawijarn W; Keast R; Karpenko D; Bogun F; Pelosi F; Morady F; Oral H
J Cardiovasc Electrophysiol; 2018 Feb; 29(2):284-290. PubMed ID: 29071765
[TBL] [Abstract][Full Text] [Related]
15. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S
J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Cost-Effectiveness Comparison of Catheter Ablation and Antiarrhythmic Drugs in Atrial Fibrillation Treatment Using Discrete Event Simulation.
Hu M; Han Y; Zhao W; Chen W
Value Health; 2022 Jun; 25(6):975-983. PubMed ID: 35667785
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of focal impulse and rotor modulation guided ablation added to pulmonary vein isolation for atrial fibrillation.
Baykaner T; Duff S; Hasegawa JT; Mafilios MS; Turakhia MP
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):526-536. PubMed ID: 29436112
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation.
Reynolds MR; Zimetbaum P; Josephson ME; Ellis E; Danilov T; Cohen DJ
Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):362-9. PubMed ID: 19808491
[TBL] [Abstract][Full Text] [Related]
19. [Cost-benefit analysis of concomitant atrial fibrillation management in Spain].
López Gude MJ; Rodríguez Bezos D; Rodríguez Barrios JM
Gac Sanit; 2010; 24(1):59-65. PubMed ID: 19931216
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome.
Hogenhuis W; Stevens SK; Wang P; Wong JB; Manolis AS; Estes NA; Pauker SG
Circulation; 1993 Nov; 88(5 Pt 2):II437-46. PubMed ID: 8222191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
